Loading...

LTRN LANTERN PHARMA INC Management Changes 8-K Filing

LNTR

LTRN

LANTERN PHARMA INC

(LTRN)

2025 8-K

AI Platform Demonstration

Financial Results Release

AI Tools Presentation

Financial Results Announcement

Annual Meeting Results

Financial Results Announcement

Equity Offerings

Financial Statements

Financial Results

Management Changes

Q3 Results Call

Q3 Earnings Announcement

Annual Meeting of Stockholders

By-laws Amendment

Earnings Reports

Earnings Reports

Management Changes

Investment Agreement

Death of Director

Earnings Reports

Annual Meeting of Stockholders

Earnings Reports

Earnings Reports

Salary Increase

External Links:

On September 19, 2025, Lantern Pharma Inc. held its Annual Meeting, electing six directors and approving a one-time repricing of stock options with 1,458,333 votes in favor. EisnerAmper LLP was ratified as the accounting firm for 2025 with 7,365,922 votes in favor.

AI Assistant

LANTERN PHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.